The instinct most directors reached for in this dilemma was disclosure, and that instinct is understandable. A funding round is built on trust. If prospective investors later discover that the company knew about an emerging operational issue and chose not to mention it, the damage may go well beyond valuation. It can affect warranties, closing conditions, investor confidence, future support, and the board’s credibility.
But this is not a simple “disclose everything immediately” case either. The facts matter. The issue has not yet affected the financials. Management is still sizing it. It may be contained within the quarter, or it may not. In that context, the board’s task is not to turn uncertainty into alarm. It is to ensure that uncertainty is understood, governed, and communicated responsibly.
The first principle is that disclosure is not the same as simply uploading a problem into the data room and leaving investors to interpret it for themselves. A number of directors made this point clearly. Disclosure without context can be as unhelpful as silence. It can distort the issue, create avoidable panic, and undermine the raise without improving investor understanding. The better approach is to disclose with framing: what is known, what is not yet known, what management is doing, who owns the issue, what the possible scenarios are, and when further clarity is expected.
The board should also distinguish between an unsized concern and an ungoverned concern. The fact that management has not fully quantified the issue does not mean the board must accept a vague “we do not know” as the answer. Directors should push management for scenarios, assumptions, risk thresholds, a bounded worst case, and a mitigation plan. Where the matter sits within the company’s risk appetite, the risk committee or relevant board committee should be involved. If the issue could become material within the round’s timeframe, the board cannot treat it as too uncertain to matter.
This is where external advice has a useful but limited role. Seeking legal, transaction or financial advice may help the board understand disclosure obligations, warranties, timing, materiality and the form of communication. But it should not become a device for delaying a decision the board already knows it must make. Advice can clarify how to disclose; it should not be used to avoid the governance question of whether investors are entitled to know.
The strongest position is that investors are not buying perfection. They are buying judgment. Most sophisticated investors expect companies to have problems. What they are testing is how early management sees them, how honestly they frame them, how well they respond, and whether the board has enough grip on the issue. Disclosing a live risk with a credible plan can build trust. Concealing it and hoping it stays small is a bet on silence, and silence rarely compounds in the board’s favour.
That said, timing and form matter. A late-stage disclosure, especially close to financial close, can create technical and legal consequences. It may affect representations and warranties, valuation, closing mechanics and investor rights. In some cases, a formal disclosure letter may not be accepted or may not protect the company in the way management assumes. This is precisely why the board should not approach disclosure as a slogan. It should be a structured decision, supported by advice, framed carefully, and aligned with the company’s transaction documents.
The defensible posture, then, is this: disclose, but disclose with context. The board should require management to size the issue as far as possible, develop scenarios and mitigation steps, seek appropriate external advice on obligations and transaction implications, and then communicate with investors in a way that is candid, proportionate and useful. The goal is not to frighten investors or to protect the round at all costs. It is to preserve trust by ensuring investors are not surprised later by something the company already knew was emerging.
In short, the board should not confuse incomplete information with irrelevant information. If the issue may reasonably influence investor judgment, it belongs in the conversation. The discipline is in how it is framed.
Voices from the discussion
A selection of contributions from board directors.
“Investing is a partnership between the company and investors, and I should be able to trust my partner to be open and honest with me. Perhaps, by disclosing, our team or the incoming club of investors has the experience and/or resources to solve the issue. Most importantly, in knowing the risks upfront, we can better assess the management team, operational processes, and the ability to be dynamic, pivot, and be resilient in the face of the unforeseen.” Lizzie Biney-Amissah
“Disclosure now, with context. I believe in fundraising; investors aren’t buying a perfect company. They’re buying judgment. Withholding the issue is a bet that it stays small. Disclosing it is a bet on trust, and trust compounds.” Linda Quaynor
“We’ve come across this situation before from the investor perspective. The company faced a risk issue that surfaced in the middle of the capital raise. The company prepared materials, including different scenarios and what actions they would take, and then jumped on calls with each individual investor to walk them through it. For most investors, this ended up being a trust-building exercise.” Lisa Thomas
“My concern with reflexive disclosure is that the board may end up passing unsized concerns to investors and calling it integrity. If the issue is not properly framed, it can look less like sound judgment and more like performing prudence.” Udo Okonjo
